Creo Medical Group (LON:CREO) Trading Down 2.9% – Here’s Why

Shares of Creo Medical Group PLC (LON:CREO) dropped 2.9% during trading on Wednesday . The stock traded as low as GBX 12.75 ($0.17) and last traded at GBX 12.75 ($0.17). Approximately 360,594 shares were traded during trading, a decline of 50% from the average daily volume of 715,357 shares. The stock had previously closed at GBX 13.13 ($0.17).

Creo Medical Group Price Performance

The firm’s fifty day simple moving average is GBX 15.85 and its 200-day simple moving average is GBX 18.75. The firm has a market capitalization of £52.55 million, a PE ratio of -2.06 and a beta of 0.86. The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96.

Insider Activity at Creo Medical Group

In other Creo Medical Group news, insider Richard John Rees acquired 4,712 shares of Creo Medical Group stock in a transaction that occurred on Thursday, January 16th. The stock was bought at an average cost of GBX 19 ($0.25) per share, for a total transaction of £895.28 ($1,158.79). 22.43% of the stock is currently owned by insiders.

Creo Medical Group Company Profile

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.